254 related articles for article (PubMed ID: 31368827)
1. Advances in technologies for cervical cancer detection in low-resource settings.
Kundrod KA; Smith CA; Hunt B; Schwarz RA; Schmeler K; Richards-Kortum R
Expert Rev Mol Diagn; 2019 Aug; 19(8):695-714. PubMed ID: 31368827
[No Abstract] [Full Text] [Related]
2. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
[TBL] [Abstract][Full Text] [Related]
3. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Kim JJ
BMC Cancer; 2017 Nov; 17(1):791. PubMed ID: 29178896
[TBL] [Abstract][Full Text] [Related]
4. Innovative approaches to cervical cancer screening in low- and middle-income countries.
Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
6. New technologies in cervical cancer screening.
Gravitt PE; Coutlée F; Iftner T; Sellors JW; Quint WG; Wheeler CM
Vaccine; 2008 Aug; 26 Suppl 10():K42-52. PubMed ID: 18847556
[TBL] [Abstract][Full Text] [Related]
7. Unmet clinical needs in cervical cancer screening.
Rao J; Escobar-Hoyos L; Shroyer KR
MLO Med Lab Obs; 2016 Jan; 48(1):8, 10, 14; quiz 15. PubMed ID: 26887092
[TBL] [Abstract][Full Text] [Related]
8. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
[TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer in low-resource settings in 2011.
Tambouret R
Arch Pathol Lab Med; 2013 Jun; 137(6):782-90. PubMed ID: 23721273
[TBL] [Abstract][Full Text] [Related]
11. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
[TBL] [Abstract][Full Text] [Related]
12. High-resolution microendoscopy: a point-of-care diagnostic for cervical dysplasia in low-resource settings.
Grant BD; Fregnani JH; Possati Resende JC; Scapulatempo-Neto C; Matsushita GM; Mauad EC; Quang T; Stoler MH; Castle PE; Schmeler KM; Richards-Kortum RR
Eur J Cancer Prev; 2017 Jan; 26(1):63-70. PubMed ID: 26637074
[TBL] [Abstract][Full Text] [Related]
13. Triage of high-risk HPV positive women in cervical cancer screening.
Ebisch RM; Siebers AG; Bosgraaf RP; Massuger LF; Bekkers RL; Melchers WJ
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1073-85. PubMed ID: 27598683
[TBL] [Abstract][Full Text] [Related]
14. Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.
Gradíssimo A; Burk RD
Expert Rev Mol Diagn; 2017 Apr; 17(4):379-391. PubMed ID: 28277144
[TBL] [Abstract][Full Text] [Related]
15. Screen and Triage by Community Extension Workers to Facilitate Screen and Treat: Task-Sharing Strategy to Achieve Universal Coverage for Cervical Cancer Screening in Nigeria.
Awolude OA; Oyerinde SO; Akinyemi JO
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30085882
[TBL] [Abstract][Full Text] [Related]
16. Cancer screening and early diagnosis in low and middle income countries : Current situation and future perspectives.
Mandal R; Basu P
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1505-1512. PubMed ID: 30353287
[TBL] [Abstract][Full Text] [Related]
17. Global strategies for cervical cancer prevention and screening.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Aug; 71(4):313-320. PubMed ID: 30808155
[TBL] [Abstract][Full Text] [Related]
18. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in optical imaging for cervical cancer detection.
Orfanoudaki IM; Kappou D; Sifakis S
Arch Gynecol Obstet; 2011 Nov; 284(5):1197-208. PubMed ID: 21800084
[TBL] [Abstract][Full Text] [Related]
20. Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening.
Liao Y; Li Q
Expert Rev Mol Diagn; 2019 Oct; 19(10):857-862. PubMed ID: 31466483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
